AAAAAA
Results:
1-7
|
Results: 7
Authors:
Mandel, RJ
Hardy, S
Snyder, RO
Naldini, L
Leff, SE
Citation: Rj. Mandel et al., Intracerebral gene transfer using viral vectors, NEUROMETH, 36, 2000, pp. 103-130
Authors:
Chen, EY
Kallwitz, E
Leff, SE
Cochran, EJ
Mufson, EJ
Kordower, JH
Mandel, RJ
Citation: Ey. Chen et al., Age-related decreases in GTP-cyclohydrolase-I immunoreactive neurons in the monkey and human substantia nigra, J COMP NEUR, 426(4), 2000, pp. 534-548
Authors:
Szczypka, MS
Mandel, RJ
Donahue, BA
Snyder, RO
Leff, SE
Palmiter, RD
Citation: Ms. Szczypka et al., Viral gene delivery selectively restores feeding and prevents lethality ofdopamine-deficient mice, NEURON, 22(1), 1999, pp. 167-178
Authors:
Leff, SE
Spratt, SK
Snyder, RO
Mandel, RJ
Citation: Se. Leff et al., Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease, NEUROSCIENC, 92(1), 1999, pp. 185-196
Authors:
Mandel, RJ
Snyder, RO
Leff, SE
Citation: Rj. Mandel et al., Recombinant adeno-associated viral vector-mediated glial cell line-derivedneurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease, EXP NEUROL, 160(1), 1999, pp. 205-214
Authors:
Mandel, RJ
Rendahl, KG
Snyder, RO
Leff, SE
Citation: Rj. Mandel et al., Progress in direct striatal delivery of L-dopa via gene therapy for treatment of Parkinson's disease using recombinant adeno-associated viral vectors, EXP NEUROL, 159(1), 1999, pp. 47-64
Authors:
Mandel, RJ
Gage, FH
Clevenger, DG
Spratt, SK
Snyder, RO
Leff, SE
Citation: Rj. Mandel et al., Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration, EXP NEUROL, 155(1), 1999, pp. 59-64
Risultati:
1-7
|